Commonground
Senior Moderator
December 15, 2009
The research team of Dr. Nguyen Hai Nam, Head of Pharmaceutical Chemistry Faculty, Hanoi University of Medicine as scientific advisor, has announced completion of stability studies and construction production process Arbidol (Fludon H1) - this drug is effects of treatment H1N1 and H5N1 influenza-like Tamiflu, Zanamivir.
Arbidol "healthy" than Tamiflu ...
In many studies show Arbidol rate effective treatment and a higher rate of drug resistance is also lower than some other drugs.
According to Dr. Nam, Arbidol the research scientists from Russia in 1973 and is licensed for circulation in many countries. Some countries, including China and Russia are using this medication very popular and effective treatment of influenza types A, B and respiratory distress syndrome SARS level. We have not recognized the harmful side effects on some 2 billion people have used.
Studies on animals showed toxic Arbidol using single low dose; experiment with high-dose lasted, Arbidol not cause mutations or fetal toxicity in animals.
Evaluate the clinical group patients Arbidol the therapeutic dose from 20-25 days showed no difference in the organs compared with using white models. This drug has demonstrated high safety.
In 160 independent clinical studies from 2002 to 2005, influenza A and B strains showed that all strains were sensitive to experimental Arbidol. Statistics on clinical practice for 15 years with Arbidol not detect cases of influenza virus resistance Arbidol.
Since June 2008, after a period of search, analysis and comparison, the research team of Dr. Nguyen Hai Men decided to focus research products containing active substances used in treating influenza Arbidol groups A, B and respiratory distress syndrome SARS levels, as the Fludon H1.
Results showed that the antiviral drug products, active control and anti-influenza immunity, especially anti-influenza group A, B and respiratory distress syndrome SARS level. Drug exposure and prevent the virus from entering human cells by preventing the lipid membrane of the virus associated with cell membranes.
Drugs work to help strengthen the body resistant to infection, reduce the frequency of complications related to viral infections and reduce the consequences of chronic bacterial infections. With virus infections, the effectiveness of treatment was seen in the low toxicity, reduced clinical symptoms and shorten the duration of treatment.
We are heading Arbidol drugs less unique. Medicine shows that the side effects of taking daily doses were recommended. Arbidol is quickly absorbed and widely distributed throughout the body.
... And cheaper to 4 times
According to the roadmap, while the Ministry of Health licensed production and drug Fludon H1 is the first drug produced in Vietnam work resistant influenza virus A/H1N1, A/H5N1, and SARS. H1 will be Fludon drug safety testing and clinical effect on the Vietnamese Men before circulation.
As planned, beginning in 2010, Fludon H1 will be available on the market price to Vietnam, with about four times cheaper than current drug Tamiflu, about 50,000 dong for a box treatment of adults, type and 200mg 20,000 VND for a box of treatment for children from 3 to 6 years of age, type of 50mg.
Dr. Nguyen Hai Men said: "Doctors can choose Fludon H1 next to preventive treatment Tamiflu for adults and children in some cases are high risk."
Experts said that the use Arbidol (Fludon H1) by the Vietnamese Men self-production in the current treatment of influenza A/H1N1 will contribute actively source treatment, reducing the number of infected influenza A/H1N1 is increasing, especially in the context of scarce drugs like Tamiflu now.
http://translate.googleusercontent....le.com&usg=ALkJrhjy8vKMkjVA2vr49bLElvvmVTTq9w
The research team of Dr. Nguyen Hai Nam, Head of Pharmaceutical Chemistry Faculty, Hanoi University of Medicine as scientific advisor, has announced completion of stability studies and construction production process Arbidol (Fludon H1) - this drug is effects of treatment H1N1 and H5N1 influenza-like Tamiflu, Zanamivir.
Arbidol "healthy" than Tamiflu ...
In many studies show Arbidol rate effective treatment and a higher rate of drug resistance is also lower than some other drugs.
According to Dr. Nam, Arbidol the research scientists from Russia in 1973 and is licensed for circulation in many countries. Some countries, including China and Russia are using this medication very popular and effective treatment of influenza types A, B and respiratory distress syndrome SARS level. We have not recognized the harmful side effects on some 2 billion people have used.
Studies on animals showed toxic Arbidol using single low dose; experiment with high-dose lasted, Arbidol not cause mutations or fetal toxicity in animals.
Evaluate the clinical group patients Arbidol the therapeutic dose from 20-25 days showed no difference in the organs compared with using white models. This drug has demonstrated high safety.
In 160 independent clinical studies from 2002 to 2005, influenza A and B strains showed that all strains were sensitive to experimental Arbidol. Statistics on clinical practice for 15 years with Arbidol not detect cases of influenza virus resistance Arbidol.
Since June 2008, after a period of search, analysis and comparison, the research team of Dr. Nguyen Hai Men decided to focus research products containing active substances used in treating influenza Arbidol groups A, B and respiratory distress syndrome SARS levels, as the Fludon H1.
Results showed that the antiviral drug products, active control and anti-influenza immunity, especially anti-influenza group A, B and respiratory distress syndrome SARS level. Drug exposure and prevent the virus from entering human cells by preventing the lipid membrane of the virus associated with cell membranes.
Drugs work to help strengthen the body resistant to infection, reduce the frequency of complications related to viral infections and reduce the consequences of chronic bacterial infections. With virus infections, the effectiveness of treatment was seen in the low toxicity, reduced clinical symptoms and shorten the duration of treatment.
We are heading Arbidol drugs less unique. Medicine shows that the side effects of taking daily doses were recommended. Arbidol is quickly absorbed and widely distributed throughout the body.
... And cheaper to 4 times
According to the roadmap, while the Ministry of Health licensed production and drug Fludon H1 is the first drug produced in Vietnam work resistant influenza virus A/H1N1, A/H5N1, and SARS. H1 will be Fludon drug safety testing and clinical effect on the Vietnamese Men before circulation.
As planned, beginning in 2010, Fludon H1 will be available on the market price to Vietnam, with about four times cheaper than current drug Tamiflu, about 50,000 dong for a box treatment of adults, type and 200mg 20,000 VND for a box of treatment for children from 3 to 6 years of age, type of 50mg.
Dr. Nguyen Hai Men said: "Doctors can choose Fludon H1 next to preventive treatment Tamiflu for adults and children in some cases are high risk."
Experts said that the use Arbidol (Fludon H1) by the Vietnamese Men self-production in the current treatment of influenza A/H1N1 will contribute actively source treatment, reducing the number of infected influenza A/H1N1 is increasing, especially in the context of scarce drugs like Tamiflu now.
http://translate.googleusercontent....le.com&usg=ALkJrhjy8vKMkjVA2vr49bLElvvmVTTq9w